| The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ... Cell reports 23 (1), 313-326. e5, 2018 | 919 | 2018 |
| Integrated molecular characterization of testicular germ cell tumors H Shen, J Shih, DP Hollern, L Wang, R Bowlby, SK Tickoo, V Thorsson, ... Cell reports 23 (11), 3392-3406, 2018 | 413 | 2018 |
| Alternative tumour-specific antigens CC Smith, SR Selitsky, S Chai, PM Armistead, BG Vincent, JS Serody Nature Reviews Cancer 19 (8), 465-478, 2019 | 327 | 2019 |
| Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma CC Smith, KE Beckermann, DS Bortone, AA De Cubas, LM Bixby, SJ Lee, ... The Journal of clinical investigation 128 (11), 4804-4820, 2019 | 266 | 2019 |
| Interleukin-23 engineering improves CAR T cell function in solid tumors X Ma, P Shou, C Smith, Y Chen, H Du, C Sun, N Porterfield Kren, ... Nature biotechnology 38 (4), 448-459, 2020 | 205 | 2020 |
| A dual immunotherapy nanoparticle improves T‐cell activation and cancer immunotherapy Y Mi, CC Smith, F Yang, Y Qi, KC Roche, JS Serody, BG Vincent, ... Advanced Materials 30 (25), 1706098, 2018 | 185 | 2018 |
| Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma A Panda, AA de Cubas, M Stein, G Riedlinger, J Kra, T Mayer, CC Smith, ... JCI insight 3 (16), 2018 | 158 | 2018 |
| Molecular subtype-specific immunocompetent models of high-grade urothelial carcinoma reveal differential neoantigen expression and response to immunotherapy R Saito, CC Smith, T Utsumi, LM Bixby, J Kardos, SE Wobker, KG Stewart, ... Cancer research 78 (14), 3954-3968, 2018 | 119 | 2018 |
| Prognostic value of B cells in cutaneous melanoma SR Selitsky, LE Mose, CC Smith, S Chai, KA Hoadley, DP Dittmer, ... Genome medicine 11, 1-11, 2019 | 104 | 2019 |
| Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors DR Beckford Vera, CC Smith, LM Bixby, DM Glatt, SS Dunn, R Saito, ... PloS one 13 (3), e0193832, 2018 | 90 | 2018 |
| CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation KE Beckermann, R Hongo, X Ye, K Young, K Carbonell, DCC Healey, ... JCI insight 5 (16), 2020 | 81 | 2020 |
| CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30+ and CD30− Embryonal Carcinoma via Antigen-Dependent and Fas/FasL Interactions LK Hong, Y Chen, CC Smith, SA Montgomery, BG Vincent, G Dotti, ... Cancer immunology research 6 (10), 1274-1287, 2018 | 73 | 2018 |
| Entinostat induces antitumor immune responses through immune editing of tumor neoantigens AS Truong, M Zhou, B Krishnan, T Utsumi, U Manocha, KG Stewart, ... The Journal of Clinical Investigation 131 (16), 2021 | 72 | 2021 |
| Machine-learning prediction of tumor antigen immunogenicity in the selection of therapeutic epitopes CC Smith, S Chai, AR Washington, SJ Lee, E Landoni, K Field, J Garness, ... Cancer immunology research 7 (10), 1591-1604, 2019 | 56 | 2019 |
| Landscape and selection of vaccine epitopes in SARS-CoV-2 CC Smith, KS Olsen, KM Gentry, M Sambade, W Beck, J Garness, ... Genome medicine 13 (1), 101, 2021 | 53 | 2021 |
| NeoSplice: a bioinformatics method for prediction of splice variant neoantigens S Chai, CC Smith, TK Kochar, SA Hunsucker, W Beck, KS Olsen, ... Bioinformatics advances 2 (1), vbac032, 2022 | 21 | 2022 |
| The dysfunction of BP180/collagen XVII in keratinocytes promotes melanoma progression BJ Hwang, Y Zhang, JM Brozowski, Z Liu, S Burette, K Lough, CC Smith, ... Oncogene 38 (50), 7491-7503, 2019 | 16 | 2019 |
| A high-avidity T-cell receptor redirects natural killer T-cell specificity and outcompetes the endogenous invariant T-cell receptor E Landoni, CC Smith, G Fucá, Y Chen, C Sun, BG Vincent, LS Metelitsa, ... Cancer immunology research 8 (1), 57-69, 2020 | 14 | 2020 |
| LENS: landscape of effective neoantigens software SP Vensko, K Olsen, D Bortone, CC Smith, S Chai, W Beckabir, M Fini, ... Bioinformatics 39 (6), btad322, 2023 | 13 | 2023 |
| Clinical features and multiplatform molecular analysis assist in understanding patient response to anti-PD-1/PD-L1 in renal cell carcinoma E Shiuan, A Reddy, SO Dudzinski, AR Lim, A Sugiura, R Hongo, K Young, ... Cancers 13 (6), 1475, 2021 | 12 | 2021 |